Emia, Kristoff Ian L.

HRN: 15-77-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2022
CEFUROXIME 750MG (VIAL)
11/14/2022
11/21/2022
IV
750mg
Q8h
PCAP B
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes